Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2012

01-09-2012 | Original Article

Efficacy of yoga based life style modification program on medication score and lipid profile in type 2 diabetes—a randomized control study

Authors: R. Nagarathna, M. R. Usharani, A. Raghavendra Rao, R. Chaku, R. Kulkarni, H. R. Nagendra

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2012

Login to get access

Abstract

Several studies have documented the beneficial short term effects of yoga in type 2 diabetics. In this prospective two-armed interventional randomized control study, 277 type 2 diabetics of both genders aged above 28 years who satisfied the study criteria were recruited from 5 zones in and around Bengaluru, India. They were allocated to a yoga-based life style modification program or exercise-based life style modification program. Integrated yoga special technique for diabetes included yogasanas, pranayama, meditation and lectures on yogic life style. Control intervention included physical exercises and life style education. Medication score, blood glucose, HbA1c and lipid profile were assessed at baseline and after 9 months. Intention to treat analysis showed better reduction (P < 0.05, Mann-Whitney test) in the dose of oral hypoglycemic medication required (Yoga - 12.8 %) (Yoga-12.3 %) and increase in HDL (Yoga-7 %) in Yoga as compared to the control group; FBG reduced (7.2 %, P = 0.016) only in the Yoga group. There was significant reduction within groups (P < 0.01) in PPBG (Yoga-14.6 %, Control-9 %), HbA1c (Yoga-14.1 %, Control-0.5 %), Triglycerides (Yoga-15.4 %, Control-16.3 %), VLDL (Yoga-21.5 %, Control-5.2 %) and total cholesterol (Yoga-11.3 %, Control-8.6 %). Thus, Yoga based life style modification program is similar to exercise-based life style modification in reducing blood glucose, HbA1c, triglycerides, total cholesterol and VLDL. Yoga is better than exercise in decreasing oral hypoglycemic medication requirement and LDL; and increasing HDL in type 2 diabetics.
Literature
1.
go back to reference Mohan V, Jaydip R, Deepa R. Type 2 diabetes in Asian Indian youth. Pediatr Diabetes. 2007;8 Suppl 9:28–34.PubMedCrossRef Mohan V, Jaydip R, Deepa R. Type 2 diabetes in Asian Indian youth. Pediatr Diabetes. 2007;8 Suppl 9:28–34.PubMedCrossRef
3.
go back to reference Ramachandran A, Snehalatha C, Sivasankari S, Hitman GA, Vijay V. Parental influence on the spectrum of type 2 diabetes in the offspring among Indians. J Assoc Physicians India. 2007;55:560–2.PubMed Ramachandran A, Snehalatha C, Sivasankari S, Hitman GA, Vijay V. Parental influence on the spectrum of type 2 diabetes in the offspring among Indians. J Assoc Physicians India. 2007;55:560–2.PubMed
4.
go back to reference Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.PubMed Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.PubMed
5.
go back to reference Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332:521–5.PubMedCrossRef Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332:521–5.PubMedCrossRef
6.
go back to reference Gross R, Olfson M, Gameroff MJ, Carasquillo O, Shea S, Feder A, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med. 2005;20:460–6.PubMedCrossRef Gross R, Olfson M, Gameroff MJ, Carasquillo O, Shea S, Feder A, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med. 2005;20:460–6.PubMedCrossRef
7.
go back to reference Williamson DF, Vinicor F, Bowman BA. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med. 2004;140:951–7.PubMed Williamson DF, Vinicor F, Bowman BA. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med. 2004;140:951–7.PubMed
8.
go back to reference Egede LE. Lifestyle modification to improve blood pressure control in individuals with diabetes: is physician advice effective? Diabetes Care. 2003;26:602–7.PubMedCrossRef Egede LE. Lifestyle modification to improve blood pressure control in individuals with diabetes: is physician advice effective? Diabetes Care. 2003;26:602–7.PubMedCrossRef
9.
go back to reference Sigal RJ, Kenny GP, Boule NG, Wells GA. Prud’homme D, Fortier M, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:357–69.PubMed Sigal RJ, Kenny GP, Boule NG, Wells GA. Prud’homme D, Fortier M, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:357–69.PubMed
10.
go back to reference Surwit RS, van Tilburg MA, Zucker N, McCaskill CC, Parekh P, Feinglos MN, et al. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care. 2002;25:30–4.PubMedCrossRef Surwit RS, van Tilburg MA, Zucker N, McCaskill CC, Parekh P, Feinglos MN, et al. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care. 2002;25:30–4.PubMedCrossRef
11.
go back to reference Surwit RS, Feinglos MN. The effects of relaxations on glucose tolerance in non-insulindependent diabetes. Diabetes Care. 1983;6:176–9.PubMedCrossRef Surwit RS, Feinglos MN. The effects of relaxations on glucose tolerance in non-insulindependent diabetes. Diabetes Care. 1983;6:176–9.PubMedCrossRef
12.
go back to reference Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;129:613–21.PubMed Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;129:613–21.PubMed
13.
go back to reference Delamater AM, Jacobson AM, Anderson B, Cox D, Fisher L, Lustman P. et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care. 2001;24:1286–92.PubMedCrossRef Delamater AM, Jacobson AM, Anderson B, Cox D, Fisher L, Lustman P. et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care. 2001;24:1286–92.PubMedCrossRef
14.
go back to reference Sundar S, Agrawal SK, Singh VP, Bhattacharya SK, Udupa KN, Vaish SK. Role of yoga in management of essential hypertension. Acta Cardiol. 1984;39:203–8.PubMed Sundar S, Agrawal SK, Singh VP, Bhattacharya SK, Udupa KN, Vaish SK. Role of yoga in management of essential hypertension. Acta Cardiol. 1984;39:203–8.PubMed
15.
go back to reference Nagarathna R, Nagendra HR. Yoga for bronchial asthma: a controlled study. Br Med J (Clin Res Ed). 1985;291:1077–9.CrossRef Nagarathna R, Nagendra HR. Yoga for bronchial asthma: a controlled study. Br Med J (Clin Res Ed). 1985;291:1077–9.CrossRef
16.
go back to reference Monro R, Powar J, Anil C, Nagarathna R, Dandona P. Yoga therapy for NIDDM- a control trial. J Complemen Med Res. 1992;6:66–8. Monro R, Powar J, Anil C, Nagarathna R, Dandona P. Yoga therapy for NIDDM- a control trial. J Complemen Med Res. 1992;6:66–8.
17.
go back to reference Manchanda SC, Narang R. Yoga and coronary artery disease. Indian Heart J. 1998;50:227–8.PubMed Manchanda SC, Narang R. Yoga and coronary artery disease. Indian Heart J. 1998;50:227–8.PubMed
18.
go back to reference Innes KE, Vincent HK. The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review. Evid Based Complement Alternat Med. 2007;4:469–86.PubMedCrossRef Innes KE, Vincent HK. The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review. Evid Based Complement Alternat Med. 2007;4:469–86.PubMedCrossRef
19.
go back to reference Nagarathna R, Nagendra HR, Monro R. Yoga for common ailments. 3rd ed. London: GAIA; 1991. Nagarathna R, Nagendra HR, Monro R. Yoga for common ailments. 3rd ed. London: GAIA; 1991.
20.
go back to reference Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi, Marathe S. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Physicians India. 2002;50:633–40.PubMed Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi, Marathe S. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Physicians India. 2002;50:633–40.PubMed
21.
go back to reference Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP. Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Physicians India. 2004;52:203–6.PubMed Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP. Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Physicians India. 2004;52:203–6.PubMed
22.
go back to reference Hegde SV, Adhikari P, Kotian S, Pinto VJ, D’Souza S, D’Souza V. Effect of 3-month yoga on oxidative stress in type 2 diabetes with or without complications: a controlled clinical trial. Diabetes Care. 2011;34:2208–10.PubMedCrossRef Hegde SV, Adhikari P, Kotian S, Pinto VJ, D’Souza S, D’Souza V. Effect of 3-month yoga on oxidative stress in type 2 diabetes with or without complications: a controlled clinical trial. Diabetes Care. 2011;34:2208–10.PubMedCrossRef
23.
go back to reference Madanmohan, Bhavanani AB, Dayanidy G, Sanjay Z, Basavaraddi IV. Effect of yoga therapy on reaction time, biochemical parameters and wellness score of peri and post-menopausal diabetic patients. Int J Yoga. 2012;5:10–5.PubMedCrossRef Madanmohan, Bhavanani AB, Dayanidy G, Sanjay Z, Basavaraddi IV. Effect of yoga therapy on reaction time, biochemical parameters and wellness score of peri and post-menopausal diabetic patients. Int J Yoga. 2012;5:10–5.PubMedCrossRef
24.
go back to reference Birdee GS, Yeh G. Complementary and Alternative Medicine Therapies for Diabetes: A Clinical Review. Clinical Diabetes. 2010;28:147–55.CrossRef Birdee GS, Yeh G. Complementary and Alternative Medicine Therapies for Diabetes: A Clinical Review. Clinical Diabetes. 2010;28:147–55.CrossRef
25.
go back to reference Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.PubMedCrossRef Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.PubMedCrossRef
26.
go back to reference Rai L, Ram K, Kant U, Madan SK, Sharma SK. Energy expenditure and ventilatory responses during Siddhasana–a yogic seated posture. Indian J Physiol Pharmacol. 1994;38:29–33.PubMed Rai L, Ram K, Kant U, Madan SK, Sharma SK. Energy expenditure and ventilatory responses during Siddhasana–a yogic seated posture. Indian J Physiol Pharmacol. 1994;38:29–33.PubMed
27.
go back to reference Schreiber WE, Busser JR, Huebsch S. Which laboratory tests do students in an internal medicine clerkship need to learn about? Am J Clin Pathol. 2008;130:696–701.PubMedCrossRef Schreiber WE, Busser JR, Huebsch S. Which laboratory tests do students in an internal medicine clerkship need to learn about? Am J Clin Pathol. 2008;130:696–701.PubMedCrossRef
29.
go back to reference St John A, Davis TM, Goodall I, Townsend MA, Price CP. Nurse-based evaluation of point-of care assays for glycated haemoglobin. Clin Chim Acta. 2006;365:257–63.PubMedCrossRef St John A, Davis TM, Goodall I, Townsend MA, Price CP. Nurse-based evaluation of point-of care assays for glycated haemoglobin. Clin Chim Acta. 2006;365:257–63.PubMedCrossRef
30.
go back to reference Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077–80.PubMed Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077–80.PubMed
31.
go back to reference Lindgren FT, Silvers A, Jutaglr R, Layshot L, Bradley DD. A comparison of simplified methods for lipoprotein quantification using the analytic ultracentrifuge as a standard. Lipids. 1977;12:278–82.PubMedCrossRef Lindgren FT, Silvers A, Jutaglr R, Layshot L, Bradley DD. A comparison of simplified methods for lipoprotein quantification using the analytic ultracentrifuge as a standard. Lipids. 1977;12:278–82.PubMedCrossRef
33.
go back to reference Heneghan C, Perera R, Ward AA, Fitzmaurice D, Meats E, Glasziou P. Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes. BMC Med Res Methodol. 2007;7:18.PubMedCrossRef Heneghan C, Perera R, Ward AA, Fitzmaurice D, Meats E, Glasziou P. Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes. BMC Med Res Methodol. 2007;7:18.PubMedCrossRef
34.
go back to reference Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7:147–77.PubMedCrossRef Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7:147–77.PubMedCrossRef
35.
go back to reference Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J Royal Stat Soc, Ser B. 1977;39:1–38. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J Royal Stat Soc, Ser B. 1977;39:1–38.
36.
go back to reference Gordon LA, Morrison EY, McGrowder DA, Young R, Fraser YT, Zamora EM, et al. Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes. BMC Complement Altern Med. 2008;8:21.PubMedCrossRef Gordon LA, Morrison EY, McGrowder DA, Young R, Fraser YT, Zamora EM, et al. Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes. BMC Complement Altern Med. 2008;8:21.PubMedCrossRef
37.
go back to reference Agrawal R, Aradhana R, Hussain S, Sabir M, Kochar D, Kothari R. Influence of yogic treatment on quality of life outcomes, glycaemic control and risk factors in diabetes mellitus. Int J Diabet Dev Ctries. 2003;23:130–4. Agrawal R, Aradhana R, Hussain S, Sabir M, Kochar D, Kothari R. Influence of yogic treatment on quality of life outcomes, glycaemic control and risk factors in diabetes mellitus. Int J Diabet Dev Ctries. 2003;23:130–4.
38.
go back to reference Agte VV, Tarwadi K. Sudarshan kriya yoga for treating type 2 diabetes: a preliminary study. Altern Complet Therap. 2004;10:220–2.CrossRef Agte VV, Tarwadi K. Sudarshan kriya yoga for treating type 2 diabetes: a preliminary study. Altern Complet Therap. 2004;10:220–2.CrossRef
39.
go back to reference Iborra RT, Ribeiro IC, Neves MQ, Charf AM, Lottenberg SA, Negrao CE, et al. Aerobic exercise training improves the role of high-density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus. Scand J Med Sci Sports. 2008;18:742–50.PubMedCrossRef Iborra RT, Ribeiro IC, Neves MQ, Charf AM, Lottenberg SA, Negrao CE, et al. Aerobic exercise training improves the role of high-density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus. Scand J Med Sci Sports. 2008;18:742–50.PubMedCrossRef
40.
go back to reference Fehm HL, Kern W, Peters A. The selfish brain: competition for energy resources. Prog Brain Res. 2006;153:129–40.PubMedCrossRef Fehm HL, Kern W, Peters A. The selfish brain: competition for energy resources. Prog Brain Res. 2006;153:129–40.PubMedCrossRef
41.
go back to reference Vempati RP, Telles S. Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels. Psychol Rep. 2002;90:487–94.PubMedCrossRef Vempati RP, Telles S. Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels. Psychol Rep. 2002;90:487–94.PubMedCrossRef
42.
go back to reference Chaya MS, Ramakrishnan G, Shastry S, Kishore RP, Nagendra H, Nagarathna R, et al. Insulin sensitivity and cardiac autonomic function in young male practitioners of yoga. Natl Med J India. 2008;21:217–21.PubMed Chaya MS, Ramakrishnan G, Shastry S, Kishore RP, Nagendra H, Nagarathna R, et al. Insulin sensitivity and cardiac autonomic function in young male practitioners of yoga. Natl Med J India. 2008;21:217–21.PubMed
43.
go back to reference Timmermans RJ, Saris WH, van Loon LJ. Insulin resistance: the role of intramuscular triglyceride and the importance of physical activity. Ned Tijdschr Geneeskd. 2006;150:122–7.PubMed Timmermans RJ, Saris WH, van Loon LJ. Insulin resistance: the role of intramuscular triglyceride and the importance of physical activity. Ned Tijdschr Geneeskd. 2006;150:122–7.PubMed
44.
go back to reference Singh S, Malhotra V, Singh K, Sharma S. A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependant diabetes. Indian J Clin Biochem. 2001;16:216–20.CrossRef Singh S, Malhotra V, Singh K, Sharma S. A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependant diabetes. Indian J Clin Biochem. 2001;16:216–20.CrossRef
Metadata
Title
Efficacy of yoga based life style modification program on medication score and lipid profile in type 2 diabetes—a randomized control study
Authors
R. Nagarathna
M. R. Usharani
A. Raghavendra Rao
R. Chaku
R. Kulkarni
H. R. Nagendra
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2012
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-012-0078-y

Other articles of this Issue 3/2012

International Journal of Diabetes in Developing Countries 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine